Efficacy and safety of tyrosine kinase inhibitors in advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutation: a network meta-analysis

AIM: To compare the efficacy and safety of tyrosine kinase inhibitors (TKIs) as first-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC) with positive EGFR mutation. MATERIALS & METHODS: Following a systematic literature review until December 2019,...

Descripción completa

Detalles Bibliográficos
Autores principales: Alanazi, Abdullah, Yunusa, Ismaeel, Elenizi, Khaled, Alzarea, Abdulaziz I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724735/
https://www.ncbi.nlm.nih.gov/pubmed/33318755
http://dx.doi.org/10.2217/lmt-2020-0011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724735/
https://www.ncbi.nlm.nih.gov/pubmed/33318755
http://dx.doi.org/10.2217/lmt-2020-0011

Ejemplares similares